急性胰腺炎病原菌分布及耐药分析:一项国内外重症数据库对比研究

Pathogens distribution and antimicrobial resistance analysis in acute pancreatitis: A comparative study of domestic and foreign critical care databases

  • 摘要:
      背景  重症监护病房内多重耐药菌(multidrug-resistant organisms,MDRO)感染发生率高,对接受重症监护的急性胰腺炎患者的抗生素治疗带来严峻挑战。
      目的  对解放军总医院(以下简称“我院”)重症胰腺炎治疗中心重症监护病房和美国重症监护医疗信息库Ⅳ版(Medical Information Mart for Intensive Care-Ⅳ,MIMIC-Ⅳ)中急性胰腺炎(acute pancreatitis,AP)病例的病原菌和耐药情况进行分析,为抗感染的经验性治疗提供依据,探讨中美抗生素耐药形势差异及带来的启示。
      方法  回顾性收集我院2018 - 2019年以及MIMIC-Ⅳ中2014 - 2019年的AP患者送检标本培养结果和药敏结果,分析AP患者感染的主要病原菌和耐药情况。
      结果  我院AP患者数量为314例,培养鉴定出微生物菌株570株;MIMIC-Ⅳ中AP患者数量为 604例,培养鉴定出微生物菌株368株。我院不同标本来源中(除尿液外)的微生物均以肺炎克雷伯菌(17.24%~26.92%)和鲍曼不动杆菌(13.56%~46.15%)为主;而MIMIC-Ⅳ中腹水、尿液和静脉血中检出最多的微生物分别为铜绿假单胞菌(17.39%)、大肠埃希菌(22.22%)和肺炎克雷伯菌(16.90%)等,呼吸道标本和中心静脉导管中以金黄色葡萄球菌(分别为28.37%和100%)最多,胆汁中凝固酶阴性葡萄球菌(21.43%)和金黄色葡萄球菌(14.29%)较多。我院肺炎克雷伯菌和鲍曼不动杆菌中MDRO的占比在90%以上,分别为94.55%和99.02%,铜绿假单胞菌和大肠埃希菌中MDRO的占比在80%以上,分别为82.14%和83.87%;MIMIC-Ⅳ中肺炎克雷伯菌、铜绿假单胞菌和大肠埃希菌中MDRO的占比分别为25.93%,27.59%和26.83%。
      结论  国内外重症数据库中急性胰腺炎患者标本分离到的微生物主要为革兰阴性菌,国外首位为金黄色葡萄球菌,国内首位为肺炎克雷伯菌,主要阴性菌耐药情况较国外明显严重。

     

    Abstract:
      Background  The high incidence of multi-drug resistant bacterial infections in intensive care units poses a serious challenge to antimicrobial therapy in patients with acute pancreatitis receiving intensive care.
      Objective  To compare the pathogens distribution and antimicrobial resistance of patients with acute pancreatitis (AP) in the Intensive Care Unit of the Center for the Treatment of Intensive Pancreatitis of Chinese PLA General Hospital (hereinafter referred to as "our hospital") and the Medical Information Mart for Intensive Care-Ⅳ (MIMIC-Ⅳ) in the United States, and provide evidences for empirical treatment of anti-infection.
      Methods  Culture results and antimicrobial sensitivity results of specimens collected from AP admitted to our hospital from 2018 to 2019 and related data in MIMIC-Ⅳ from 2014 to 2019 were retrospectively collected and compared.
      Results  The number of AP patients in our hospital was 314, and 570 microbial strains were identified in culture; whereas the number of AP patients in MIMIC-Ⅳ was 604, and 368 microbial strains were identified in culture. Microorganisms in different specimen sources (except urine) in our hospital were predominantly Klebsiella pneumoniae (17.24%-26.92%) and Acinetobacter baumannii (13.56%-46.15%), while the most detected microorganisms in ascites, urine and venous blood in MIMIC-Ⅳ were Pseudomonas aeruginosa (17.39%), Escherichia coli (22.22%) and Klebsiella pneumoniae (16.90%), respectively, and Staphylococcus aureus was mostly abundant in respiratory specimens and central venous catheters (28.37% and 100%, respectively), and coagulase-negative Staphylococcus (21.43%) and Staphylococcus aureus (14.29%) were more common seen in bile. The percentage of multidrug-resistant organisms (MDRO) among Klebsiella pneumoniae and Acinetobacter baumannii in our hospital was over 90% (94.55% and 99.02%, respectively), and the percentage of that among Pseudomonas aeruginosa and Escherichia coli was over 80% (82.14% and 83.87%, respectively), while in MIMIC-Ⅳ, the percentage of MDRO among Klebsiella pneumoniae, Pseudomonas aeruginosa and Escherichia coli were 25.93%, 27.59% and 26.83%, respectively.
      Conclusion  The main Gram-negative bacteria isolated from patients with AP in domestic and foreign critical care databases are mainly Gram-negative bacteria. The most common is Staphylococcus aureus in MIMIC-Ⅳ and Klebsiella pneumoniae in our hospital. And the drug resistance of the main negative bacteria is more serious than in foreign countries.

     

/

返回文章
返回